Trial Profile
A placebo-controlled, parallel group study of HTU-520 in patients with onychomycosis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Registrational; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 25 May 2016 New trial record